- Home
- TSHA vs GNE Comparison
TSHA vs GNE Comparison
Compare TSHA & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- GNE
- Stock Information
- Founded
- TSHA 2019
- GNE 2011
- Country
- TSHA United States
- GNE United States
- Employees
- TSHA N/A
- GNE N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- GNE Power Generation
- Sector
- TSHA Health Care
- GNE Utilities
- Exchange
- TSHA Nasdaq
- GNE Nasdaq
- Market Cap
- TSHA 728.4M
- GNE 718.9M
- IPO Year
- TSHA 2020
- GNE N/A
- Fundamental
- Price
- TSHA $2.94
- GNE $15.47
- Analyst Decision
- TSHA Strong Buy
- GNE
- Analyst Count
- TSHA 7
- GNE 0
- Target Price
- TSHA $8.71
- GNE N/A
- AVG Volume (30 Days)
- TSHA 2.7M
- GNE 211.4K
- Earning Date
- TSHA 08-12-2025
- GNE 08-07-2025
- Dividend Yield
- TSHA N/A
- GNE 1.94%
- EPS Growth
- TSHA N/A
- GNE 4.51
- EPS
- TSHA N/A
- GNE 0.31
- Revenue
- TSHA $8,098,000.00
- GNE $456,876,000.00
- Revenue This Year
- TSHA N/A
- GNE $13.72
- Revenue Next Year
- TSHA N/A
- GNE $6.96
- P/E Ratio
- TSHA N/A
- GNE $38.45
- Revenue Growth
- TSHA N/A
- GNE 3.75
- 52 Week Low
- TSHA $1.05
- GNE $13.05
- 52 Week High
- TSHA $3.31
- GNE $28.47
- Technical
- Relative Strength Index (RSI)
- TSHA 62.34
- GNE 20.81
- Support Level
- TSHA $2.69
- GNE $15.42
- Resistance Level
- TSHA $3.12
- GNE $16.60
- Average True Range (ATR)
- TSHA 0.17
- GNE 0.86
- MACD
- TSHA 0.02
- GNE -0.32
- Stochastic Oscillator
- TSHA 68.97
- GNE 3.53
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.